Ryan Specialty Holdings, Inc. (RYAN)
NYSE: RYAN · Real-Time Price · USD
69.42
-0.65 (-0.93%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Company Description
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, and Singapore.
The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
It serves commercial, industrial, institutional, and government sectors. The company was founded in 2010 and is headquartered in Chicago, Illinois.
Ryan Specialty Holdings, Inc.
Country | United States |
Founded | 2010 |
IPO Date | Jul 22, 2021 |
Industry | Insurance - Specialty |
Sector | Financials |
Employees | 5,250 |
CEO | Timothy Turner |
Contact Details
Address: 155 North Wacker Drive, Suite 4000 Chicago, Illinois 60606 United States | |
Phone | 312 784 6001 |
Website | ryanspecialty.com |
Stock Details
Ticker Symbol | RYAN |
Exchange | NYSE |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $23.50 |
CIK Code | 0001849253 |
CUSIP Number | 78351F107 |
ISIN Number | US78351F1075 |
SIC Code | 6411 |
Key Executives
Name | Position |
---|---|
Catherine Gill | Chief Executive Officer of LifeScienceRisk |
Emil Issavi | Chief Executive Officer and President of Ryan Re Underwriting Managers |
Brendan Martin Mulshine | Executive Vice President and Chief Revenue Officer |
Anthony Hanes | President of Stetson Insurance Funding, LLC |
Noah S. Angeletti | Senior Vice President and Treasurer |
Michael Schulz | Senior Vice President and Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 17, 2025 | ARS | Filing |
Apr 17, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 17, 2025 | DEF 14A | Other definitive proxy statements |
Apr 4, 2025 | PRE 14A | Other preliminary proxy statements |
Mar 27, 2025 | 8-K | Current Report |
Mar 14, 2025 | 144 | Filing |
Feb 21, 2025 | 10-K | Annual Report |
Feb 20, 2025 | 8-K | Current Report |
Feb 13, 2025 | SCHEDULE 13G/A | Filing |
Jan 30, 2025 | 144 | Filing |